VOGLISLOW 0.2 is a specialized oral medication designed to help manage blood sugar levels in individuals with type 2 diabetes. Containing the active ingredient Voglibose (0.2mg), this medication is primarily used to delay the absorption of glucose from the intestine, thus helping to control postprandial blood sugar spikes. VOGLISLOW 0.2 is an integral part of diabetes management, especially when used in conjunction with diet and exercise.

Key Benefits:

• Helps Control Postprandial Hyperglycemia: VOGLISLOW 0.2 is specifically designed to control blood sugar spikes after meals, making it an essential medication for individuals with type 2 diabetes.
• Improves Glycemic Control: Regular use of this medication can significantly improve overall glycemic control when combined with other antidiabetic therapies.
• Supports Diabetes Management: By managing postprandial blood sugar levels, VOGLISLOW 0.2 reduces the risk of long-term complications associated with diabetes.

How Does It Work?

VOGLISLOW 0.2 works by inhibiting the enzyme alpha-glucosidase in the intestines. This enzyme is responsible for breaking down carbohydrates into glucose, which is then absorbed into the bloodstream. By inhibiting this enzyme, Voglibose slows down the breakdown and absorption of carbohydrates, thereby reducing the postprandial rise in blood glucose levels. This action helps in better managing diabetes and preventing complications related to high blood sugar levels.

Directions for Use:

• Take VOGLISLOW 0.2 exactly as prescribed by your healthcare provider.
• It is typically taken just before or with the first bite of each meal.
• Swallow the tablet whole with water; do not crush or chew it.
• Follow your prescribed diet and exercise regimen while using this medication.

Side Effects:

While VOGLISLOW 0.2 is generally well-tolerated, some individuals may experience side effects, including:

• Abdominal Discomfort: Mild to moderate abdominal pain or discomfort may occur due to delayed carbohydrate digestion.
• Flatulence: Increased gas production is a common side effect due to undigested carbohydrates reaching the colon.
• Diarrhea: Some users may experience diarrhea as a result of the delayed absorption of sugars.
• Hypoglycemia: When taken with other antidiabetic medications, there is a potential risk of low blood sugar levels (hypoglycemia).

If You Need More Information About VOGLISLOW 0.2  Click here